CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing the licensing agreement that 48North Cannabis Corp (TSX-V:NRTH) has entered with Mother & Clone Inc.

Market Trends  

Women, overall, are responsible for 70-80% of consumer spending and the burgeoning cannabis market is no different than any other in this respect. Studies are showing that female consumers are embracing cannabis from both a health & wellness and recreational standpoint, and they want cannabis products that are discreet, easy to consume, and don't affect their ability to function in their day-to-day activities.  

Now two key specialty players in the women's cannabis sector have joined forces to develop products focused on these particular women's buying trends.  

A Perfect Union

48North Cannabis Corp (TSX-V:NRTH) has announced that it has entered into a licensing agreement with Mother & Clone, Inc. ("Mother & Clone"), a Colorado-based company producing proprietary cannabis sublingual nanosprays (a form of measured microdosing).

Canadian production and sale of Mother & Clone products are expected to commence after 48North receives its Health Canada license amendment permitting the sale of cannabis oil since the Company already holds a supplemental license for the extraction and production of cannabis oil.

Per the licensing agreement, 48North will be the exclusive Canadian licensed producer of all present and future Mother & Clone products for domestic Canadian consumption and global export. Mother & Clone will earn a ten percent licensing fee on the gross profit on all Canadian and international sales. The agreement provides for production from the unique cultivars grown at 48North's state-of-the-art, closed-box, 40,000-square-foot DelShen facility, using existing the research and development of Mother & Clone's proprietary, strain-specific nano-particle delivery system.

A Strategic Alliance for a Worldwide Niche Market

"It is fitting that our first official partnership and portfolio addition is with Mother & Clone, a woman-led and focused cannabis company with a unique product offering," said Alison Gordon, Chief Executive Officer at 48North. "This deal includes product distribution, brand familiarity and intellectual property ownership over all Mother & Clone products and will give us a competitive lead in bringing next-generation wellness products to the Canadian and international markets."

"Partnering with 48North aligns with Mother & Clone's brand positioning, corporate values and shared focus on women's lifestyle and wellness through cannabis in the adult recreational space," said Leslie Siu, Chief Executive Office of Mother & Clone.

Because Mother & Clone‘s strain-specific sublingual products are uniquely formulated for rapid absorption under the tongue, with effects that are felt within minutes and last about an hour, these worry-free Ph.D. formulated cannabis products are likely to appeal to cannabis-minded women.   

Growing Trends in Female Cannabis Consumption

According to a recent survey from BDS Analytics, menstruation, menopause, and sex were listed as the top reasons for female cannabis consumption. As part of its Cannabis Wellness Trends Series, BDS Analytics recently conducted a consumer insights survey of 1,281 women in four states where cannabis sales are legal: California, Colorado, Oregon and Washington.  

The study revealed that, at least in the women's market, cannabis consumption was common across all ages. Younger women are increasingly turning to marijuana as a natural alternative to manage mood swings and premenstrual pain, and older women, transitioning through menopause, choosing cannabis products to supplement or replace estrogen therapy and improve their sleep. Additionally, 25% of women consumers reported reduced use of prescription medications, and 33% reported reduced use of over-the-counter medications since starting a cannabis regimen. Women are clearly taking a bigger interest in cannabis-based products in areas where recreational use is approved.

Looking Ahead

With the legalization of recreational cannabis in Canada, the health and wellness market is garnering a greater interest in incorporating more cannabis-based products for domestic use in Canada, as well as future opportunities for exporting to markets around the world. Investors are taking note of these kinds of market trends and paying special attention to public companies that are taking a leading edge in the cannabis health and wellness sector. 48North Cannabis Corp (TSX-V:NRTH), with its unique niche market, is one such company to watch.

For more information, visit the company's website at www.48nrth.com.

Please follow the link to read the full article: http://www.cannabisfn.com/48north-joins-forces-mother-clone-license-sublingual-nanospray-canada/